References
Schoels M, Wong J, Scott DL, et al. Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2010;69:995–1003.
Marra CA, Marion SA, Guh DP, et al. Not all “quality-adjusted life years” are equal. J Clin Epidemiol. 2007;60:616–24.
Maetzel A, Li LC, Pencharz J, et al. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis. 2004;63:395–401.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patel, A.M., Lupash, D., Chew, D. et al. Cost-Effectiveness of Biologics Compared with Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. Curr Rheumatol Rep 13, 381–382 (2011). https://doi.org/10.1007/s11926-011-0197-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-011-0197-3